As essential copies of semaglutide become less available, we're securing access to FDA-approved options and exploring alternatives to support continued care
For biosimilar developers, the equivalent analysis focuses on the 351(k) landscape: reference product exclusivity expiration dates (which establish the earliest possible FDA approval date), the biosimilar patent dance posture (whether to engage or opt out), and the competitive field of other biosimilar developers targeting the same reference product
For example, a recent study indicated that unlike in mouse islets where tirzepatide stimulates insulin secretion predominantly through the GLP-1R, the therapeutic effects of tirzepatide on human beta and alpha cells require engagement of both the GLP-1R and the GIPR, and in addition, tirzepatide increased glucagon secretion in isolated islets [207]
" "Stephanie was so sweet & gentle
R., Calabresi, L., Ferrara, S., Pazzucconi, F., Bondioli, A., Baldassarre, D., Birreci, A., and Koverech, A
Methods: Presence and severity of 16 symptoms potentially related to PSC were identified from the Our Voices survey